Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000‐2018
Alimentary Pharmacology & Therapeutics2020Vol. 51(10), pp. 922–934
Citations Over TimeTop 10% of 2020 papers
Dominic King, Raoul C. Reulen, Tom Thomas, Joht Singh Chandan, Rasiah Thayakaran, Anuradhaa Subramanian, Krishna Gokhale, Neeraj Bhala, Krishnarajah Nirantharakumar, Nicola J. Adderley, Nigel Trudgill
Abstract
The UK prevalence of inflammatory bowel disease is greater than previous reports suggest and we predict an 11% increase in prevalence by the year 2025. Mortality risk in inflammatory bowel disease and colorectal cancer risk in ulcerative colitis are increased compared to matched controls.
Related Papers
- → Bioinspired and biomimetic strategies for inflammatory bowel disease therapy(2024)8 cited
- → Special Issue “Dietary Bioactive Components in Inflammatory Bowel Disease”(2024)3 cited
- → Origins and Directions of Inflammatory Bowel Disease, Early Studies of the “Nonspecific” Inflammatory Bowel Diseases(2003)6 cited
- → Mo1835 PREVALENCE OF OCULAR DISEASES IN INFLAMMATORY BOWEL DISEASE (IBD): A NATIONAL, POPULATION-BASED STUDY(2020)
- → 31288 Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases(2022)